Literature DB >> 9005442

Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion.

S M Kipriyanov1, M Little, H Kropshofer, F Breitling, S Gotter, S Dübel.   

Abstract

In antigen-antibody interactions, the high avidity of antibodies depends on the affinity and number of the individual binding sites. To develop artificial antibodies with multiple valency, we have fused the single-chain antibody Fv fragments to core streptavidin. The resulting fusion protein, termed scFv::strep, was found after expression in Escherichia coli in periplasmic inclusion bodies. After purification of the recombinant product by immobilized metal affinity chromatography, refolding and size-exclusion FPLC, tetrameric complexes resembling those of mature streptavidin were formed. The purified tetrameric scFv::strep complexes demonstrated both antigen- and biotin-binding activity, were stable over a wide range of pH and did not dissociate at high temperatures (up to 70 degrees C). Surface plasmon resonance measurements in a BIAlite system showed that the pure scFv::strep tetramers bound immobilized antigen very tightly and no dissociation was measurable. The association rate constant for scFv::strep tetramers was higher than those for scFv monomers and dimers. This was also reflected in the apparent constants, which was found to be 35 times higher for pure scFv::strep tetramers than monomeric single-chain antibodies. We could also show that most of biotin binding sites were accessible and not blocked by biotinylated E.coli proteins or free biotin from the medium. These sites should therefore facilitate the construction of bispecific multivalent antibodies by the addition of biotinylated ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9005442     DOI: 10.1093/protein/9.2.203

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  16 in total

Review 1.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

2.  Biotin carboxyl carrier protein co-purifies as a contaminant in core-streptavidin preparations.

Authors:  Welson Wen-Shang Wang; Dipankar Das; Mavanur R Suresh
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

3.  Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.

Authors:  Nathalie Scholler; Barbara Garvik; Travis Quarles; Shaoyi Jiang; Nicole Urban
Journal:  J Immunol Methods       Date:  2006-10-30       Impact factor: 2.303

4.  A versatile bifunctional dendritic cell targeting vaccine vector.

Authors:  Welson W Wang; Dipankar Das; Mavanur R Suresh
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

5.  Creation and Evaluation of a Single-chain Antibody Tetramer that Targets Brain Endothelial Cells.

Authors:  Xiaobin Zhang; Xin Xiang Wang; Eric V Shusta
Journal:  AIChE J       Date:  2014-04-01       Impact factor: 3.993

6.  Fluorogen-activating scFv biosensors target surface markers on live cells via streptavidin or single-chain avidin.

Authors:  Eugenio Gallo; Jonathan Jarvik
Journal:  Mol Biotechnol       Date:  2014-07       Impact factor: 2.695

7.  Prevention of human rhinovirus infection by multivalent fab molecules directed against ICAM-1.

Authors:  Catherine H Charles; Guang X Luo; Lori A Kohlstaedt; Ianessa G Morantte; Elliott Gorfain; Linguang Cao; Jimmy H Williams; Fang Fang
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

8.  Novel affinity tag system using structurally defined antibody-tag interaction: application to single-step protein purification.

Authors:  Terukazu Nogi; Takeshi Sangawa; Sanae Tabata; Masamichi Nagae; Keiko Tamura-Kawakami; Ayako Beppu; Mitsuharu Hattori; Norihisa Yasui; Junichi Takagi
Journal:  Protein Sci       Date:  2008-09-11       Impact factor: 6.725

9.  Development of a streptavidin-conjugated single-chain antibody that binds Bacillus cereus spores.

Authors:  K Koo; P M Foegeding; H E Swaisgood
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792

10.  Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris.

Authors:  Steve Schoonooghe; Vladimir Kaigorodov; Monika Zawisza; Caroline Dumolyn; Jurgen Haustraete; Johan Grooten; Nico Mertens
Journal:  BMC Biotechnol       Date:  2009-08-11       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.